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Sulfur mustard or mustard gas (HD) and its monofunctional analog, 2-chloroethyl ethyl sulﬁde (CEES), or “half-mustard gas”,
are alkylating agents that induce DNA damage, oxidative stress, and inﬂammation. HD/CEES are rapidly absorbed in the skin
causingextensive injury. We hypothesize that antioxidantliposomes that deliver both water-soluble and lipid-soluble antioxidants
protect skin cells from immediate CEES-induced damage via attenuating oxidative stress. Liposomes containing water-soluble
antioxidants and/or lipid-soluble antioxidants were evaluated using in vitro model systems. Initially, we found that liposomes
containingencapsulatedglutathione(GSH-liposomes)increasedcell viabilityandattenuated production ofreactive oxygenspecies
(ROS)inHaCaTcellsexposed toCEES.Next, GSH-liposomeswere testedinahumanepidermalmodel,EpiDerm.IntheEpiDerm,
GSH-liposomes administered simultaneously or 1 hour after CEES exposure (2.5mM) increased cell viability, inhibited CEES-
induced lossofATP andattenuated changesincellularmorphology,butdidnotreduce caspase-3activity. Theseﬁndingsparalleled
the previously described in vivo protective eﬀect of antioxidant liposomes in the rat lung and established the eﬀectiveness of GSH-
liposomes in a human epidermal model. This study provides a rationale for use of antioxidant liposomes against HD toxicity in
the skin considering further veriﬁcation in animalmodels exposed to HD.
1.Introduction
Sulfur mustard (military code HD) is a weapon of mass-
destruction that is relatively simple to synthesize; it is lethal
in high doses and causes severe damage to skin, lungs,
respiratory tract, and eyes [1]. The most prominent toxic
eﬀects of HD are to dermal tissues where it produces severe
damageincludingextremely slowhealinglesionsandblisters,
which can ulcerate and promote secondary infections [2,
3]. Despite the long military history of HD, the molecular
mechanisms for its toxicity are not fully elucidated and an
eﬀective countermeasure has remained elusive. Both HD
and CEES (a monofunctional analog of sulfur mustard) are
alkylating agents that covalently react with nucleic acids,
proteins, and intracellular glutathione (GSH). GSH is a key
intracellular antioxidant that is depleted by exposure to HD
or CEES [4, 5]. A considerable body of evidence supports
the notion that oxidative stress is an important factor in
promoting HD/CEES toxicity and that antioxidants such as
GSH or NAC could be important countermeasures [5–13].
Recent studies haveshown that GSH and NAC,especially
ifused asa pretreatment, notonly increase viability ofCEES-
treated keratinocytes, but also attenuate CEES toxicity in
SKH-1hairlessmouseskin[14,15].Theeﬀectivenessofthese
antioxidants in cultured cells and animal models suggests
that an oral application of GSH and/or NAC should be
considered as a potential countermeasure to the HD/CEES
toxicity in humans. However, certain diﬃculties of such
approach should be taken to account. First, the antioxidants
areeﬀectiveonlyduringashortperiodaftertheexposure(≤1
hour).Second,theeﬀectivedoseof GSHin theanimal exper-
iments was 300mg/kg [15], which suggests that the eﬀective2 Journal of Toxicology
GSH dose in human should be in the range of few tens of
grams. Therefore, a systemic application in humans would
be diﬃcult due to the requirement of large amounts of
solid or liquid antioxidants for a single treatment. A topical
application seems to be more appropriate; however, the
absorption of water-soluble antioxidants is minimal after
the topical application (less than 1% of the applied dose
penetrates the stratum corneum). Thus, we suggest that the
treatment design should be based on the combination of
the antioxidants with an eﬀective delivery system for topical
application.
Antioxidant liposomes, spherical nanoparticles consist-
ing of phospholipid bilayer(s) with an aqueous compart-
ment, possess the unique ability to eﬀectively deliver both
lipid soluble chemical antioxidants (in the lipid bilayer) and
water-soluble chemical antioxidants (in the aqueous phase)
[16, 17]. Moreover, liposomes rapidly penetrate the dermal
barrier making the delivery of water-soluble compounds as
eﬀective as lipid-soluble drugs [18]. In contrast with other
drug carriers such as DMSO [19], liposomes are absolutely
harmless tohuman skin since theyare composedofnaturally
occurring biodegradable phospholipids. In previous studies,
it has been demonstrated that antioxidant liposomes with
encapsulated NAC and antioxidant enzymes protect lung
epithelial cells and reduce lymphocyte inﬁltration in rats
intratracheally exposed to CEES [20–22]. We suggest that
antioxidant liposomes could be useful as a multifunctional
therapy since liposomal formulations similar to those used
in the rat lung studies could also be protective in skin. In
the present study, we tested the ability of several liposomal
formulations containing water-soluble antioxidants (NAC
or GSH) and/or lipid-soluble antioxidants (tocopherols or
alpha-lipoic acid) to attenuate CEEStoxicity after the dermal
exposure. The protective eﬀects of liposomes were initially
studied in HaCaT human keratinocytes exposed to sulfur
mustard analog, CEES. The most protective GSH-containing
liposomes were then tested in a human epidermal model,
EpiDerm.
2.Materialsand Methods
2.1. Materials and Reagents. Stemline Keratinocyte Medium
II(withoutL-glutamine,calcium-free),ﬂuorimetricCaspase-
3 Assay Kit, Sigma Luciferase ATP Determination kit,
CEES, NAC, GSH, cholesterol, RRR-alpha-tocopherol, RRR-
gamma-tocopherol, R-alpha-lipoic acid, DMSO, EDTA, and
all organic solvents were obtained from Sigma Chemical
Company (Sigma-Aldrich Inc., St. Louis, Mo). CellTiter 96
Aqueous One Solution Cell Proliferation Assay kit based on
MTS (3-(4,5-dimethyl-2-yl)-5-(3-carboxymethoxyphenyl)-
2-(4-sulfophenyl)-2H-tetrazolium,innersalt)waspurchased
from Promega Corporation (Madison, Wis). Soybean phos-
pholipid mixture phospholipon 90G was obtained from
American Lecithin Company (Oxford, Conn).
2.2. Cell Culture and Treatments. Spontaneously immor-
talized human keratinocytes HaCaT were purchased from
Cell Lines Service (Eppelheim, Germany). HaCaT cells were
cultured at 37◦C in a humidiﬁed incubator with 5% CO2
in Stemline Keratinocyte Medium II (without L-glutamine,
calcium-free) supplied with 10% fetal bovine serum Sigma
Chemical Company (St. Louis, Mo). Adherent cells were
subcultured over night in 96 well Costar tissue culture plates
in the Keratinocyte Medium II and treated with CEES in
the presence or absence of various concentrations of antiox-
idants or antioxidant liposomes as indicated in the ﬁgures.
CEES was used only as fresh stock solutions in anhydrous
DMSO, which was quickly mixed with culture medium im-
mediately prior to incubation (ﬁnal concentration of DMSO
was 1% (vol./vol.)). CEES ﬁnal concentration of 1mM was
chosen as it stably reduced HaCaT viability to 20–30% in
our experimental settings (preliminary experiments). This
observationisinaccordancewithﬁndingspublishedbyother
investigators [14, 15].
EpiDerm human skin model system EPI-200 and condi-
tioning medium were purchased from MatTek Corporation
(Ashland, Mass). EpiDerm is an in vitro human skin equiv-
alent that consists of normal, human-derived epidermal ker-
atinocytes(NHEK),whichhavebeenculturedtoformamul-
tilayered, highly diﬀerentiated model of the human epider-
mis (http://www.mattek.com/pages/products/epiderm). The
EpiDerm tissues in a clear plastic 24-well plate were recon-
ditioned overnight according to the manufacturer’s instruc-
tions. CEES-containing media (freshly mixed) were applied
topically (250μL per tissue) into the plate insert. Treatments
(free antioxidant solutions or antioxidant liposomes) pre-
mixed in the culture media were applied by changing the
bottom media. NAC and GSH are capable of scavenging
mustardelectrophilesinsolution[23,24].Inordertoprevent
direct interaction of the antioxidant liposomes with CEES,
GSH- or NAC-containing liposomes were added into the
bottommedia, whereas CEEScontainingmedia were applied
to EpiDerm tissues topically.
Water-solubleantioxidants (GSHorNAC)wereprepared
as 0.5M stock solutions in PBS (pH adjusted to 7.4), ﬁlter-
sterilized, and stored at 4◦C for two weeks or less. Lipo-
philic antioxidants (alpha-tocopherol, gamma-tocopherol,
oralpha-lipoic acid)were prepared as 50mM stock solutions
in anhydrous ethanol and stored at −20◦C.
2.3. Antioxidant Liposome Preparation and Application.
Antioxidant liposomes were prepared by extrusion of the
phospholipid/cholesterol dry ﬁlm emulsiﬁed in PBS [25].
Six types of antioxidant liposomes (see Table 1)w e r em a d e
by the extrusion technique using a small extruder apparatus
purchased from Avanti Polar Lipids Inc. (Alabaster, Ala)
according to manufacturer’s instructions. Prior to extrusion,
a lipid ﬁlm was prepared in a 2mL glass vial by mixing the
lipid-soluble component stock solutions in chloromethane
(phospholipon 90G, cholesterol with or without tocopherols
or alpha-lipoic acid) with subsequent evaporation of the
solvent undera nitrogen stream. The thin lipid ﬁlm was then
hydratedanddetachedbyvigorousmixing inPBS(whichdid
or did not contain water-soluble antioxidants GSH or NAC)
at 30◦C. Solubilized large multilamellar vesicles were then
extruded through a polycarbonate membrane with 100nmJournal of Toxicology 3
Table 1: Liposome composition.
Type of liposomes
Blank GSH NAC AT GT ALA
Lipid components Concentration (mole fractions)
Phospholipon 90G 0.71 0.71 0.71 0.70 0.70 0.70
cholesterol 0.29 0.29 0.29 0.28 0.28 0.28
α-tocopherol 0 0 0 0.02 0 0
γ-tocopherol 0 0 0 0 0.02 0
α-lipoic acid 0 0 0 0 0 0.02
Aqueous∗ components Concentration (mM)
GSH 0 200 0 0 0 0
NAC 0 0 200 0 0 0
∗All aqueous components were used as solutions in sterile PBS; liposomes that do not contain aqueous components were prepared with sterile PBS also.
Blank: Blank liposomes (contain no antioxidant); GSH: reduced glutathione; NAC: N-acetyl-L-cysteine; AT: alpha-tocopherol; GT: gamma-tocopherol; ALA:
alpha-lipoic acid.
size pores (Avanti Polar Lipids Inc., Alabaster, Ala) at 50◦C.
The resulting liposomes, large unilamellar vesicles with a
mean diameter 120 ± 30nm, were used the next day or
stored at 4◦C for one week or less. Liposomes of this size
provide relatively high antioxidants/phospholipids ratio and
are not large enough to stimulate macrophages. Liposomes
of this size have been successfully used to attenuate CEES
toxicity in various models [20–22, 26]. Size distribution of
the liposomes was monitored in PBS by using dynamic light
scattering with a Nicomp 380 Particle Sizing Systems (Port
Richey, Fla). If liposomes were stored for more than one
day their size distribution, the main parameter of liposome
stability, was monitored again prior to the treatment. All of
our liposome preparations appeared stable for at least one
week.
In the tissue culture experiments, antioxidant liposomes
(Table 1) or antioxidant solutions/suspensions in PBS (as
controls) were applied to HaCaT cells simultaneously with
CEES. In the EpiDerm experiments, antioxidant liposomes
(containing 200mM NAC or GSH encapsulated) or antioxi-
dant solutions in PBS (as controls) were applied to EpiDerm
tissues via the bottom membrane (diluted 1:20 (v/v) in the
bottommedia, thusproviding a “calculated”ﬁnal concentra-
tion of 10mM) and simultaneously with CEES, which was
applied topically. Such application excluded direct contact
between CEES and liposomes, therefore preventing possible
absorption of CEES by liposomal phospholipids and subse-
quent hydrolysis of CEES by the aqueous liposomal interior.
Thus,liposomesdidnotdirectlyinterfere withCEEStoxicity.
Overall design of these experiments was developed in accor-
dancewiththestudiesofCEEStoxicityintheEpiDermmod-
els [27–29] as well as with the studies of the protective eﬀects
of antioxidant liposomes in various models [20–22, 26].
2.4.Cell Viability Assays. The PI assay in theHaCaTcells was
performed by a slight modiﬁcation of the method described
earlier [30]. Brieﬂy, at the end of each experiment, cultured
cells in 96 well dark plates with clear bottom (200μLo f
medium per well) were incubated with PI (ﬁnal concen-
tration 2μg/mL) at 37◦C for 30min. PI ﬂuorescence in the
dead cells was measured using a Fluostar Galaxy microplate
reader (BMG, Germany) at an excitation wavelength of
485nm and an emission wavelength of 650nm. The results
were calculated using the formula: viability (%) = 100 ×
(1– [(Test Sample – Low Control)/(High Control – Low
Control)]), where Test Sample is ﬂuorescence of the cells
exposed to CEES or vehicle, Low Control is ﬂuorescence
of the cells in medium without CEES or vehicle (negative
control, minimal ﬂuorescence), High Control is ﬂuorescence
ofthecellsincubatedinmediumcontaining1%TritonX-100
(positive control, maximal ﬂuorescence).
The MTS assay in the HaCaT cells and in the EpiDerm
tissues was performed using CellTiter 96 Aqueous One
Solution (MTS solution) according to the manufacturer’s
instruction. Brieﬂy, at the end of each experiment, cultured
cells in clear plastic multiwell plates were incubated with
CellTiter 96 Aqueous One Solution (diluted 1:20 (v/v) with
medium)at37◦Cfor1.5hours.ForHaCaTkeratinocytes,the
MTS solution was applied by complete change of the culture
medium. For EpiDerm tissues, CellTiter 96 Aqueous One
Solution was diluted into fresh bottom media and applied
simultaneously with CEES or vehicle(applied topically).The
formazan derived from MTS is water soluble (unlike MTT
formazan product that needs to be dissolved in DMSO) and
does not require additional washout or any separation of the
cells prior to the OD measurement. The formazan product
produced by viable cells was detected by a visual inspection,
andtheODwasmeasured at590nmwith aSpectraMaxPlus
384microplatereader(MolecularDevices,Sunnyvale,Calif).
In our preliminary experiments, blank liposomes con-
taining phospholipids and cholesterol only (see Table 1)d i d
not show any eﬀect on cell growth inhibition after 24 or
48 hour incubation; also, they did not attenuate the eﬀect
of CEES signiﬁcantly (data not shown). Therefore, we used
blank liposomes as a control.
2.5. Caspase-3 and ATP Assays. Caspase-3 assay (an apopto-
sis index) and intracellular ATP measurements (drastic ATP
loss reﬂects necrosis) were performed by assaying cell lysates4 Journal of Toxicology
using the Caspase-3 Assay Kit and the Sigma Luciferase
ATP Determination kit, respectively, (Sigma-Aldrich Inc.,
S t .L o u i s ,M o )a c c o r d i n gt om a n u f a c t u r e r ’ si n s t r u c t i o n s .
Caspase-3 and ATP were measured in the cell lysates in order
to estimate relative contribution of apoptosis and necrosis
in the cell death mechanism in the EpiDerm. Staurosporine
(5μM) was used to induce apoptosis (positive control). To
prepare cell lysates, EpiDerm tissues were carefully removed
from insert membranes using a sterile forceps and placed in
1.5mLmicrocentrifugetubes.Avolumeof100μLofSomatic
cellATPreleasingreagent(Sigma-AldrichInc.,St.Louis,Mo)
was added to each tube. Each tissue was crushed into pieces
using a small pestle. The homogenized mixture was vortexed
brieﬂy, and then frozen at −80◦C. The next day the samples
were allowed to thaw for 15min at room temperature. Then
the tubes were centrifuged at 4◦C for 30min at 16,000 ×g.
The supernatant ﬂuids, designated the tissue lysates, were
transferred to fresh plastic tubes and were placed on ice
until assayed. All assays were performed immediately upon
preparation of tissue lysates.
2.6. Microscopic Examinations. At the end of incubation
with CellTiter 96 Aqueous One Solution (containing MTS)
EpiDerm tissues were rinsed with cold sterile PBS, removed
from insert membranes using forceps, placed on aluminium
foil and frozen at −80◦C. For sectioning, each tissue was
ﬁxed between two thick layers of OCT (Optimal Cutting
Temperature) compound. The “sandwich” was cut in half
and ﬁxated on a microtable with OCT compound in order
to make vertical cuts. Tissue slices (25μm thickness) were
made on Leica Rapid Sectioning Cryostat CM 1900 (Meyer
Instruments Inc., Houston, Tex), put on glass slides and
ﬁxed with formalin solution (Sigma-Aldrich Inc., St. Louis,
Mo) without additional staining. Slides were examined and
photographed using a BX51 Olympus Microscope equipped
with a CC12 digital camera (Olympus America Inc., Center
Valley, Pa).
2.7. Fluorescent Microscopic Examinations. HaCaT cell den-
sity was adjusted to 2 × 105/mL, and a 100μL aliquot of
the cell suspension in media was placed in each well of an
8-well Lab-Tek chamber glass slide (Nunc, Rochester, NY).
Vehicle (1% DMSO) or CEES (1mM) in the presence or
absenceof10mMGSH(eitherencapsulatedintheliposomes
(GSH-liposomes) or nonencapsulated (free GSH)) were si-
multaneously added to chamber slides and incubated for 6
hour (to evaluate ROS generation due to CEES exposure)
or 18 hours (to evaluate total thiol depletion due to CEES
exposure) at 37◦Ci n5 %C O 2. The time period for the
ROS monitoring experiment was relatively short in order to
account for relatively short lifespan of ROS particles. At the
end of the incubation (6 or 18 hours, resp.) 100x stock solu-
tion of 6-carboxy-2 ,7 -dichlorodihydroﬂuorescein diacetate
(carDCFH-DA; H2O2-sensitive probe for intracellular ROS
monitoring) or 5-chloromethylﬂuorescein diacetate (CMF-
DA; nonprotein thiol sensitive probe for intracellular thiols,
including GSH) in DMSO was added (ﬁnal carDCFH-
DA or CMF-DA concentration was 10 μM) and the slides
were further incubated for 20min at 37◦Ci nt h ed a r k .
100μMtert-butylhydroperoxide(TBHP)wasusedtoinduce
oxidative stress in the absence of CEES or antioxidants
(positive control). The cells were washed with cold PBS
twice, observed, and digitally photographed using a MOTIC
inverted phase contrast ﬂuorescence microscope equipped
with a Nikon Coolpix E4300 4-megapixel camera (Martin
Microscope, Easley, SC). Vehicle-treated sample stained with
carDCFH-DA were photographed as merged images (green
ﬂuorescence and phase contrast) in order to visualize live
cellsintheabsenceofﬂuorescence.Thenumberoflivingcells
(green ﬂuorescence) was determined after counting ≥200
cells in the squares (4 squares per sample) of same size for
each condition tested. Data were expressed as mean ± SD
percent reduction from control.
2.8. Statistical Analyses. Data were analyzed by ANOVA
followed with the Scheﬀe test for signiﬁcance with P<
.05 using SPSS 17.0 for Windows (Chicago, Ill). Results
were expressed as the mean ± SD. In all the ﬁgures, mean
values not sharing a common letter are signiﬁcantly diﬀerent
(P<. 05). Mean values sharing a common letter are
not signiﬁcantly diﬀerent. The mean values and standard
deviations of at least three independent experiments are
provided in all the ﬁgures.
3.Results
3.1. The Protective Eﬀect of Various Antioxidant Liposomes
in HaCaT Cells. We ﬁrst performed a series of preliminary
experiments testing the eﬀect of various antioxidant lipo-
someformulationsinHaCaTkeratinocytesexposedtoCEES.
Six types of liposomes containing various antioxidants:
Blank (no antioxidants), NAC, GSH, alpha-tocopherol (AT),
gamma-tocopherol (GT), or alpha-lipoic acid (ALA) were
used for the initial experiments in HaCaT cells. Figure 1
shows HaCaT cell viability (MTS assay) after the exposure
to 1mM CEES and simultaneous treatment with “free” or
liposome-encapsulated water-soluble antioxidants (NAC
or GSH). The eﬀects of antioxidant liposomes on the cell
proliferation were measured by the MTS assay after 18 hour
incubation (see Section 2). These results were conﬁrmed
with viability assays using the ﬂuorescent probe propidium
iodine (PI) that stains dead cells (data not shown). Both
assays showed similar patterns for cell survival (PI) and for
cell growth inhibition (MTS). Only water-soluble antioxi-
dants (NAC and GSH) were eﬀective in these experiments.
Both 5mM and 10mM GSH-liposomes prevented CEES-
induced decrease of cell viability in HaCaT keratinocytes
(Figure 1(a)). In a similar experiment, NAC-liposomes also
showed a dose-dependent increase in cell viability with
the maximum at 10mM, however, the eﬀect was slightly
lower compared to GSH-liposomes (Figure 1(b)). GSH-
liposomes were the most protective since they increased cell
viability from 28% (blank liposomes) to 67% (10mM GSH,
liposome encapsulated). However, the eﬀects of liposome-
encapsulated NAC and GSH were equal to the eﬀects of
nonencapsulated “free” NAC and GSH. The lipid-solubleJournal of Toxicology 5
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Figure 1: Protective eﬀects of “free” and liposome-encapsulated antioxidants in HaCaT cells. GSH (a) or NAC (b), either “free” (as stock
solutionsin PBS)or encapsulated in the phospholipid-based liposomes(calculated ﬁnalconcentrationas indicated), were applied to HaCaT
cells simultaneously with 1mM CEES or vehicle (1% DMSO); blank liposomes (no antioxidant encapsulated) or PBS were used as controls
forGSH- orNAC-liposomes andfor“free” GSH orNAC, respectively. Cells were incubated at37◦C for18 hours.Cellviability wasmeasured
using the MTS assay (see Section 2). Mean values not sharing a common letter are signiﬁcantly diﬀerent (P<. 05).
antioxidants (alpha-tocopherol, gamma-tocopherol, or al-
pha-lipoic acid) were not protective when liposome-encap-
sulated or as suspensions in PBS (data not shown).
3.2. GSH Prevents ROS Generation and Thiol Depletion in
HaCaT Cells. In order to show that CEES induces oxidative
stress in the HaCaT cells we performed a series of ﬂuorescent
microscopy experiments monitoring ROS and thiol status of
t h eC E E S - t r e a t e dc e l l si nt h ep r e s e n c ea n di nt h ea b s e n c e
of GSH-liposomes (Figure 2). As evidenced by carDCFH-
DA ﬂuorescence, intracellular H2O2,am a j o rm a r k e ro f
ROS generation, was enhanced upon the CEES treatment
(6 hours); however, in the presence of GSH-liposomes or
“free” GSH, ROS production was almost fully abolished
(Figure 2(a)). CEES exposure (18 hours) also reduced aver-
age number of viable cells counted under microscope (14.7
± 8.2% of control) and promoted total thiol depletion
(Figure 2(b)); the eﬀect was attenuated in the presence of
GSH-liposomes (33.1 ± 9.5% of control), as well as in the
presence of “free” GSH (28.4 ± 11.5% of control). These
observations provide additional evidence that the GSH-
liposomes eﬀectively protect human keratinocytes exposed
to CEES and attenuate CEES-induced ROS production and
thioldepletion,althoughtheeﬀectofliposome-encapsulated
GSH was similar to the eﬀect of “free” GSH. These data
also suggest that in HaCaT keratinocytes, GSH-liposomes
provide eﬀective intracellular GSH delivery.
3.3. The Eﬀects of Antioxidant Liposomes in the EpiDerm
Model. EpiDerm tissue consists of organized basal, spinous,
granular, and corniﬁed layers of diﬀerentiating epidermal
human keratinocytes that closely mimic human epidermis.
At present, EpiDerm is one of the best available in vitro
models of human skin and has successfully been used to
study CEES toxicity in vitro [27, 28]. At ﬁrst, we explored
cytotoxic eﬀect of CEES in EpiDerm tissues. A dose-
dependent decrease of cell viability due to CEES (0.5–
5.0mM) exposure was observed (data not shown). CEES
concentration of 2.5mM reduced cell viability within the
EpiDerm tissues to 48 ± 8.6%, and this concentration was
chosen for the following experiments to study the eﬀect of
antioxidants.
We tested the protective eﬀect of GSH- and NAC-
containing liposomes in EpiDerm tissues exposed to CEES.
We found that only GSH-liposomes increased cell viability
(Figure 3(a)) and reduced ATP depletion (Figure 3(b))i n
the EpiDerm tissues topically exposed to 2.5mM CEES.
GSH-liposomes added immediately after CEES provided an
extremely eﬀective countermeasure to CEES toxicity since
both cell viability (Figure 3(a))a n dA T Pl e v e l( Figure 3(b))
did not signiﬁcantly decrease from their original levels as
observed in cells treated with vehicle alone. The attenuation
of ATP depletion in keratinocytes evidenced that GSH-
liposomes reduce necrosis induced by CEES.
3.4. The Eﬀect of Antioxidant Liposomes on Apoptosis in
the EpiDerm Model. We also evaluated the ability of GSH-
liposomes to inﬂuence apoptosis in CEES-treated EpiDerm
tissues using the caspase-3 assay (Figure 4). CEES and HD
induce both apoptosis and necrosis in human cell lines
including HaCaT keratinocytes. However, relatively low dos-
es ofHD inducemostly apoptosis, whereas higherdoses pro-
mote necrosis [31, 32] .T h u s ,i ti sl i k e l yt h a tC E E S≥2.5mM
would promote mostly necrosis with only limited induction
of apoptosis. Indeed, at a level of 2.5mM, CEES induced
a relatively low level of apoptosis in EpiDerm (Figure 4).
Considering the marked loss of ATP (Figure 3(b)), necrosis,
but not apoptosis is likely the major cause of cell death at
this level of CEES. Figure 4 also shows that GSH-liposomes
did not inhibit the apoptosis induced by 2.5mM CEES.
These experiments suggest that GSH-liposomes are eﬀective6 Journal of Toxicology
1.5mM CEES CEES + GSH-liposomes CEES + free GSH
TBHP (pos. cont.) Vehicle + GSH-liposomes Vehicle + free GSH
(a)
CEES + free GSH
Vehicle Vehicle + GSH-liposomes
1.5mM CEES CEES + GSH-liposomes
Vehicle + free GSH
(b)
Figure 2: GSH prevents ROS generation and thiol depletion in HaCaT cells. HaCaT cells were treated with vehicle (1% DMSO) or 1.5mM
CEES (as indicated) in the presence or absence of “free” GSH or GSH-liposomes (as indicated), simultaneously. Cells were incubated at
37◦C for 6 hours and then stained with 10μM carDCFH-DA to monitor ROS generation (a); alternatively, cells were incubated at 37◦Cf o r
18 hours and then stained with 10μM CMF-DA to access intracellular nonprotein thiols (b). 100μM TBHP (tert-butyl hydroperoxide) was
used as a positive control (to induce oxidative stress). Live cells were photographed under a ﬂuorescent microscope (200x magniﬁcation)
equipped with a standard FITC ﬁlter. Vehicle-treated sample stained with carDCFH-DA (a) shows merged images (green ﬂuorescence and
phase contrast) in order to visualize live cells in the absence of ﬂuorescence.
in blocking CEES toxicity and necrosis, but do not prevent
apoptosis in the EpiDerm model.
3.5.TheProtectiveEﬀect ofGSH-Liposomesin EpiDerm Model
(Posttreatment). In order to test the potential protective
eﬀect of GSH-liposomes under posttreatment conditions,
we performed an experiment, in which NAC- or GSH-
liposomes were applied to EpiDerm one or two hours after
the CEES (2.5mM) exposure. Only GSH-liposomes and
“free” GSH showed signiﬁcant protection in this experi-
ment (Figure 5). In the EpiDerm tissues, CEES exposure
reduced cell viability to 24 ± 5%; GSH-liposomes applied
simultaneously with CEES altered cell viability to 87 ± 9%;
GSH-liposomes applied one hour after CEES altered cellJournal of Toxicology 7
V
e
h
i
c
l
e
+
B
-
l
i
p
o
s
o
m
e
s
C
E
E
S
+
B
-
l
i
p
o
s
o
m
e
s
C
E
E
S
+
N
A
C
-
l
i
p
o
s
o
m
e
s
C
E
E
S
+
G
S
H
-
l
i
p
o
s
o
m
e
s 0
20
40
60
80
100
120
V
e
h
i
c
l
e
C
E
E
S
C
e
l
l
v
i
a
b
i
l
i
t
y
(
%
)
a a a
b
b
b
(a)
V
e
h
i
c
l
e
C
E
E
S
a a
a
b
b
b
0
20
40
60
80
100
120
140
A
T
P
c
o
n
t
e
n
t
(
%
o
f
c
o
n
t
r
o
l
)
V
e
h
i
c
l
e
+
B
-
l
i
p
o
s
o
m
e
s
C
E
E
S
+
B
-
l
i
p
o
s
o
m
e
s
C
E
E
S
+
N
A
C
-
l
i
p
o
s
o
m
e
s
C
E
E
S
+
G
S
H
-
l
i
p
o
s
o
m
e
s
(b)
Figure 3: Protective eﬀects of antioxidant liposomes in the EpiDerm model. EpiDerm tissues were exposed topically to 2.5mM CEES or
vehicle (1% DMSO) in the absence or presence of Blank liposomes (B-liposomes), NAC-liposomes, and GSH-liposomes (as indicated)
applied simultaneouslywith CEES or vehicle, but into the bottom media; the tissues were incubated at 37◦C for 18 hours. Final “calculated”
concentration of GSH or NAC was 10mM (see Section 2). Cell viability was monitored by the MTS assay (a). Cellular ATP was assayed in
the tissue homogenates by the ATP assay(b). Means not sharing a common letter are signiﬁcantly diﬀerent (P<. 05).
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Figure 4: GSH-liposomes do not reduce apoptosis in the EpiDerm
model. EpiDerm tissues were exposed topically to 2.5mM CEES
or vehicle (1% DMSO) in the absence or presence of Blank
liposomes (B-liposomes) or GSH-liposomes (as indicated) applied
simultaneously with CEES or vehicle, but into the bottom media;
the tissues were incubated at 37◦C for 18 hours. Final “calculated”
concentration of GSH was 10mM (see Section 2). Caspase-3
activitywasassayedinthetissuehomogenatesbythecaspase-3assay
(see Section 2). Blank: blank buﬀer (negative control); Staur.: 5μM
staurosporine (positive control). Means not sharing a common
letter are signiﬁcantly diﬀerent (P<. 05).
viability to 52 ± 11%; GSH-liposomes applied two hours
after CEES altered cell viability to 32 ± 12%. Although the
latter(twohours) eﬀectw asn ots ign iﬁ can t,theeﬀectofone-
hour posttreatment with GSH-liposomes was statistically
signiﬁcant, and the toxicity of CEES was attenuated substan-
tially(two-folddiﬀerence).NAC-liposomesdidnotshowany
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Figure 5:Protective eﬀectsof GSH-liposomesorfreeGSH inEpiDerm
(posttreatment). EpiDerm tissues were exposed topically to 2.5mM
CEES or vehicle (1% DMSO) in the absence or presence of Blank
liposomes (B-liposomes) or GSH-liposomes (as indicated) applied
simultaneously with CEES or vehicle, but into the bottom media
(sim: simultaneous application; post: 1 hour post-treatment). Final
“calculated” concentration of GSH was 10mM (see Section 2).
Cell viability was monitored after 18 hours by the MTS assay (see
Section 2). Means not sharing a common letter are signiﬁcantly
diﬀerent (P<. 05).
statistically signiﬁcant protective eﬀect in the posttreatment
experiments (data not shown).
3.6. The Inﬂuence of GSH-Liposomes on Cellular Morphol-
ogy Changes in EpiDerm. It is known that HD and its
analogs induce morphological changes in keratinocytes, in8 Journal of Toxicology
Vehicle
(a)
2.5mM CEES
(b)
2.5mM CEES + B-liposomes
(c)
2.5mM CEES + GSH-liposomes
(d)
Figure 6: Protective eﬀectof GSH-liposomes inthe EpiDerm model. EpiDerm tissues were topically exposed to vehicle (1% DMSO)or 2.5mM
CEES in the absence or presence of GSH-liposomes or Blank liposomes (B-liposomes). After the MTS assay EpiDerm tissues were frozen,
dissected, and photographed under a light microscope with 400x magniﬁcation (see Section 2). Violet color reﬂects the accumulation of the
MTS formazan product in the proliferating keratinocytes. Note the disruption of the keratin ﬁlament structure in the stratum corneum in
the presence of CEES, and the increase of proliferating (violet) basal keratinocytes in the presence of GSH-liposomes.
particular, HD aﬀects size and shape of the cells and induces
fragmentation of the extracellular matrix [3]. In order to
determine whether GSH-liposomes inﬂuence keratinocyte
morphology, we performed microscopic examinations of
EpiDerm tissues incubated with CEES in the presence or
absence of GSH-liposomes; tissues were stained with MTS
at the end of the incubation to visualize viable cells. After
CEES (2.5mM) exposure the apical side of the keratinocyte
multilayershowed the matrix disassembly (the cells lost their
compact structure within the tissue and prominent gaps
appear in the matrix); the integrity of the cell multilayer
was markedly disturbed and the majority of proliferating
cells were detached and lost. The remaining cells formed
a dense structure with a very limited number of live cells.
The remaining live cells appeared violet in color due to the
reduction of MTS dye by functioning mitochondria; these
cells showed size reduction and round shape (Figure 6).
This observation is in agreement with recent study of
CEES toxicity in the EpiDerm full-thickness skin equivalents
[29]. Treatment with blank liposomes (composed with
phospholipids only) did not aﬀect the CEES-exposed cells,
however, marked changes were observed upon simultaneous
treatment with CEES and GSH liposomes (Figure 6). The
number of live keratinocytes increased as observed by
the MTS staining; some live cells retained normal shape;
however, the overall integrity of the tissue was somewhat
lower if compared to the control (tissues exposed to vehicle
only).
4.Discussion
Our studies with the human epidermal model, EpiDerm,
showed that GSH, both “free” and “liposome encapsulated,”
attenuated toxicity induced by CEES, a mustard gas analog.
In our experimental settings, antioxidant liposomes and
CEES were applied separately (topically and to the bottom
media, resp.) in order to prevent their direct interaction
and scavenging of CEES by the liposomes. Systemic appli-
cation of free GSH would require consumption of large
amounts of solid or liquid antioxidants because hydrophilic
compounds poorly penetrate the stratum corneum; there-
fore, antioxidant liposomes would provide a reasonable
alternative, especially after the dermal exposure. Moreover,
the liposome design presents an additional advantage as it
allows encapsulating of multiple lipophilic and hydrophilic
components. For instance, antioxidants can be combined
with anti-inﬂammatory drugs as inﬂammation plays a role
in the developmentof skin lesions [33].
At a relatively high CEES dose (2.5mM), the major cause
of cell death in our studies was necrosis with only a slight
additional eﬀect caused by apoptosis. Our results indicated
that the GSH liposomes not only enhanced cell viability inJournal of Toxicology 9
EpiDerm tissues exposed to CEES, but also reduced necrosis
asevidencedbyinhibitionofATPdepletioninducedbyCEES
exposure. On the other hand, as shown by the caspase-3
activity measurements, GSH liposomes had no signiﬁcant
eﬀect on CEES-induced apoptosis (2.5mM CEES). This is
in accord with numerous studies of CEES or HD toxicity
to various cell lines including human keratinocytes [3]. In
endothelial cells and lymphocytes [6, 34, 35]a n da l s oi n
HaCaT keratinocytes [31, 32], relatively low doses of HD
induced mostly apoptosis, whereas higher doses promoted
necrosis. Chiarugi, [36] has shown that a potent alkylating
agent, if applied to the cells at a suﬃcient level, induces a
“programmable” form of necrosis due to a genotoxic stress.
Necrosis is a more inﬂammatory form of cell death. In epi-
dermal keratinocytes, necrosis, but not apoptosis, promotes
inﬂammatory responses [37–40]. Invarious skin models, the
open wounds due to HD exposure were highly susceptible
to infections and showed many typical characteristics of
necrotic tissues [2, 31]. Thus, in the search for therapeutic
countermeasures to HD, it is important to show that the
prospectivetreatmentnotonlyincreasescellviabilitybutalso
reduces necrosis. In our recent work, we have discussed an
“apoptosis-to-necrosis switch” in the HaCaT cells exposed to
CEES [41].
The molecular mechanisms of CEES/HD toxicity in
human skin have not been fully investigated. Recent ﬁndings
strongly suggest, however, that these mechanisms are com-
plex; they involve DNA and other macromolecular damage,
oxidative stress and inﬂammation [3, 33]. It is widely
accepted that ROS generation and oxidative damage play a
critical role in these mechanisms. In the EpiDerm model,
GSH liposomes showed signiﬁcant protective eﬀect even
when applied 1 hour after CEES exposure. This observation
further conﬁrmed previous in vitro studies of CEES/HD
toxicity, which have demonstrated that the antioxidants
that reduce oxidative stress and prevent thiol depletion also
attenuate CEES toxicity, whereas oxidants (hydrogen per-
oxide) [4] and agents that deplete intracellular glutathione
(buthioninesulphoximine) [6, 42] sensitize human cell lines,
in particular HaCaT [42], to CEES/HD toxicity. Thus, our
study provides additional evidence of the critical role of
oxidative stress in the pathogenesis of CEES/HD-induced
injury in the skin. Although the protective eﬀects of various
antioxidants are well documented both in vitro and in vivo
[2, 3], it is possible that in the human skin, the antioxidants
are eﬀective only when applied prior to or short time after
(about 1 hour) CEES/HD exposure. For instance, in human
endothelialcells, NACalteredcellviabilityonlywhen applied
simultaneously or prior to HD [6]. Similarly, in a guinea
pig model, superoxide dismutase, a powerful antioxidant
enzyme, reduced skin lesions only when applied prior to
HD exposure [43]. It should be taken into account that
the main direct chemical impact of the alkylating agents,
such as HD or CEES, within the cell is attributable to the
DNA damage derived from rapid alkylation of guanines
by mustard sulfonium ions [3, 24]; NAC and GSH (as
nucleophilic scavengers) are capable of scavenging mustard
electrophiles in the cytosol [23, 24]. However, this direct
detoxiﬁcation is possible only during a short time after
the exposure, and other nucleophilic scavengers, for exam-
ple, thiopurines [23] or exogenous peroxidases [44], are
more eﬀective in degrading of HD or CEES. Nevertheless,
antioxidants and antioxidant liposomes have shown a great
potential in preventive treatment of CEES/HD toxicity [3–
5, 9, 10, 20, 21, 26, 34, 42, 45–48]. In addition, it is well
known that mammalian skin cells exposed to CEES/HD
release proinﬂammatory cytokines [27, 28, 37, 49]a n do t h e r
immune stimulators [50]. These immune factors mediate
inﬂammatory responses that contribute to the development
of skin lesions [33]. Therefore, in a long run, it is critical not
only to protect keratinocytes from immediate cell injuries,
but also to reduce the inﬂammatory responses in the skin
[3, 33]. This approach will require deeper understanding of
themolecularmechanisms ofCEES/HDtoxicityinmulticell-
type and animal models.
In summary, we foundthat GSHliposomeshaveshown a
protective eﬀect (viability increase, ATP content protection,
oxidative stress reduction) in the EpiDermmodel exposed to
CEES, a close analog of mustard gas. The molecular mech-
a n i s m so ft h ep r o t e c t i v ee ﬀect of GSH-liposomes involved
reduction of necrosis (but not apoptosis). In addition, GSH
liposomes attenuated ROS generation and intracellular thiol
depletion that were induced by CEES. We suggest that in
the EpiDerm model, GSH-liposomes protect the cells from
necrosis not only by scavenging of CEES electrophiles, but
also by reduction of oxidative stress and inﬂammation.
The hypothesis, however, needs more evidence, and that is
being addressed in a separate study. Although the protective
eﬀect of liposome-encapsulated GSH was limited in time
and not statistically diﬀerent to the eﬀect of “free” GSH,
we suggest that preventive or “quick-response” antioxidant
therapy may be a useful strategy against mustard toxicity
in human skin, especially considering the fact that water-
soluble antioxidants cannot penetrate epidermis if applied
to the skin as a solution, whereas the liposomes possess
superiordeliveryabilitiesindermalapplications[18].Taking
into account previously described antioxidant liposome-
derived protection in lung tissues [20–22, 26], we suggest
that a multifunctional liposomal formulation containing
encapsulated antioxidants will be eﬀective against sulfur
mustard toxicity both in the skin and in the lung.
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